Patents by Inventor Takashi Kurasawa
Takashi Kurasawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12078139Abstract: A vehicle includes a first power system, a second power system, a switching relay, and a relay controller. The first power system is coupled to an engine restart motor. The second power system is provided independently of the first power system and is coupled to a starter and an accessory. The coupling state of the switching relay is switchable to an on state in which the first power system and the second power system are coupled, and to an off state in which the first power system and the second power system are not coupled. The relay controller is configured to receive a supply of electric power from both the first power system and the second power system and to control the coupling state of the switching relay.Type: GrantFiled: November 7, 2022Date of Patent: September 3, 2024Assignee: SUBARU CORPORATIONInventors: Akashi Yoshizawa, Takashi Inoue, Tetsuo Kobayashi, Shinya Kurasawa
-
Patent number: 9486446Abstract: The present invention provides an orally-disintegrating solid preparation comprising fine granules showing controlled release of a pharmaceutically active ingredient, wherein the outermost layer of the fine granules is coated with a coating layer comprising hydroxypropylmethylcellulose and low-substituted hydroxypropylcellulose and breakage of the fine granules during tableting is suppressed.Type: GrantFiled: December 27, 2007Date of Patent: November 8, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Takashi Kurasawa, Yasuko Watanabe, Yohko Akiyama
-
Publication number: 20160128945Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: December 28, 2015Publication date: May 12, 2016Inventors: Yohko AKIYAMA, Takashi KURASAWA, Hiroto BANDO, Naoki NAGAHARA
-
Patent number: 9241910Abstract: The present invention provides an orally-disintegrating solid preparation such as a tablet produced by tabletting fine granules showing controlled release of a pharmaceutically active ingredient and an additive, and the like, and the orally-disintegrating solid preparation containing fine granules coated with a coating layer containing a polymer affording a casting film having an elongation at break of about 100-about 700%. With the preparation, breakage of fine granules during tabletting can be suppressed in the production of an orally-disintegrating solid preparation containing fine granules showing controlled release of a pharmaceutically active ingredient.Type: GrantFiled: March 10, 2009Date of Patent: January 26, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Takashi Kurasawa, Yasuko Watanabe, Yoshihiro Omachi
-
Publication number: 20150037423Abstract: The present invention provides an orally-disintegrating solid preparation such as a tablet produced by tabletting fine granules showing controlled release of a pharmaceutically active ingredient and an additive, and the like, and the orally-disintegrating solid preparation containing fine granules coated with a coating layer containing a polymer affording a casting film having an elongation at break of about 100-about 700%. With the preparation, breakage of fine granules during tabletting can be suppressed in the production of an orally-disintegrating solid preparation containing fine granules showing controlled release of a pharmaceutically active ingredient.Type: ApplicationFiled: October 21, 2014Publication date: February 5, 2015Inventors: Takashi KURASAWA, Yasuko WATANABE, Yoshihiro OMACHI
-
Patent number: 8784885Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: GrantFiled: July 19, 2010Date of Patent: July 22, 2014Assignee: Takeda Pharmaceutical Company LimitedInventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara
-
Publication number: 20140186449Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: March 6, 2014Publication date: July 3, 2014Inventors: Yohko AKIYAMA, Takashi KURASAWA, Hiroto BANDO, Naoki NAGAHARA
-
Publication number: 20140186448Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: March 6, 2014Publication date: July 3, 2014Inventors: Yohko AKIYAMA, Takashi KURASAWA, Hiroto BANDO, Naoki NAGAHARA
-
Patent number: 8722084Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: GrantFiled: July 8, 2010Date of Patent: May 13, 2014Assignee: Takeda Pharmaceutical Company LimitedInventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara
-
Publication number: 20110091563Abstract: The present invention provides an orally-disintegrating solid preparation such as a tablet produced by tabletting fine granules showing controlled release of a pharmaceutically active ingredient and an additive, and the like, and the orally-disintegrating solid preparation containing fine granules coated with a coating layer containing a polymer affording a casting film having an elongation at break of about 100-about 700%. With the preparation, breakage of fine granules during tabletting can be suppressed in the production of an orally-disintegrating solid preparation containing fine granules showing controlled release of a pharmaceutically active ingredient.Type: ApplicationFiled: March 10, 2009Publication date: April 21, 2011Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Takashi Kurasawa, Yasuko Watanabe, Yoshihiro Omachi
-
Publication number: 20100316709Abstract: The present invention provides an orally-disintegrating solid preparation comprising fine granules showing controlled release of a pharmaceutically active ingredient, wherein the outermost layer of the fine granules is coated with a coating layer comprising hydroxypropylmethylcellulose and low-substituted hydroxypropylcellulose and breakage of the fine granules during tableting is suppressed.Type: ApplicationFiled: December 27, 2007Publication date: December 16, 2010Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Takashi Kurasawa, Yasuko Watanabe, Yohko Akiyama
-
Publication number: 20100285120Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: July 19, 2010Publication date: November 11, 2010Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara
-
Publication number: 20100278911Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: July 8, 2010Publication date: November 4, 2010Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara
-
Publication number: 20100272798Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: July 8, 2010Publication date: October 28, 2010Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Yohko AKIYAMA, Takashi KURASAWA, Hiroto BANDO, Naoki NAGAHARA
-
Patent number: 7790755Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: GrantFiled: October 15, 2003Date of Patent: September 7, 2010Assignee: Takeda Pharmaceutical Company LimitedInventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara
-
Publication number: 20090175959Abstract: The present invention provides a controlled release solid preparation superior in the stability of an active ingredient, which can exhibit pharmacological effects steadily and rapidly after administration, and shows a sustained pharmacological effect for a prolonged period of time: a controlled release solid preparation containing (1) an antacid, (2) an immediate-release part containing a compound unstable to acid and a basic substance, and (3) a sustained-release part containing a compound unstable to acid and a pH-independent material in combination.Type: ApplicationFiled: December 28, 2006Publication date: July 9, 2009Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Hiroto Bando, Takashi Kurasawa
-
Publication number: 20090104264Abstract: The present invention provides a controlled release solid preparation superior in the stability of an active ingredient, which can exhibit pharmacological effects steadily and rapidly after administration, and shows a sustained pharmacological effect for a prolonged period of time: a controlled release solid preparation containing a combination of (1) an antacid, (2) an immediate-release part containing a compound unstable to acid and a basic substance, and (3) a sustained-release part containing a compound unstable to acid and a basic substance, and having a film that dissolves at pH 6.5 or above.Type: ApplicationFiled: December 28, 2006Publication date: April 23, 2009Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Hiroto Bando, Takashi Kurasawa
-
Publication number: 20060013868Abstract: A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.Type: ApplicationFiled: October 15, 2003Publication date: January 19, 2006Inventors: Yohko Akiyama, Takashi Kurasawa, Hiroto Bando, Naoki Nagahara